|Systematic (IUPAC) name|
|AHFS/Drugs.com||International Drug Names|
|ATC code||C10AD01 (WHO)|
|Molar mass||556.523 g/mol|
|(what is this?)|
Niceritrol is a niacin derivative used as a hypolipidemic agent. It is an ester of pentaerythritol and nicotinic acid, has general properties similar to those of nicotinic acid (Nicotinamide), to which it is slowly hydrolysed. Niceritrol has been used as a lipid regulating drug in hyperlipidaemias and as a vasodilator in the treatment of peripheral vascular disease.
- Owada A.; Suda S; Hata T. (2003). "Antiproteinuric effect of niceritrol, a nicotinic acid derivative, in chronic renal disease with hyperlipidemia: a randomized trial.". Am J Med 114 (5): 347–53. PMID 12714122.
- Truven Health Analytics Inc. (May 8, 2008). "Niceritrol". Micromedexsolutions.com. Retrieved December 14, 2014.
|This drug article relating to the cardiovascular system is a stub. You can help Wikipedia by expanding it.|